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Background: Despite recent improvements in malaria prevention strategies, malaria case management remains a
weakness in Northern Nigeria, which is underserved and suffers the country’s highest rates of under-five child
mortality. Understanding malaria care-seeking patterns and comparing case management outcomes to World
Health Organization (WHO) and Nigeria’s National Malaria Control Programme (NMCP) guidelines are necessary to
identify where policy and programmatic strategies should focus to prevent malaria mortality and morbidity.
Methods: A cross-sectional survey based on lot quality assurance sampling was used to collect data on malaria
care-seeking for children under five with fever in the last two weeks throughout Sokoto and Bauchi States. The
survey assessed if the child received NMCP/WHO recommended case management: prompt treatment, a diagnostic
blood test, and artemisinin-based combination therapy (ACT). Deviations from this pathway and location of
treatment were also assessed. Lastly, logistic regression was used to assess predictors of seeking treatment.
Results: Overall, 76.7% of children were brought to treatment—45.5% to a patent medicine vendor and 43.8% to a
health facility. Of children brought to treatment, 61.5% sought treatment promptly, but only 9.8% received a
diagnostic blood test and 7.2% received a prompt ACT. When assessing adherence to the complete case
management pathway, only 1.0% of children received NMCP/WHO recommended treatment. When compared to
other treatment locations, health facilities provided the greatest proportion of children with NMCP/WHO
recommended treatment. Lastly, children 7–59 months old were at 1.74 (p = 0.003) greater odds of receiving
treatment than children ≤6 months.
Conclusions: Northern Nigeria’s coverage rates of NMCP/WHO standard malaria case management for children
under five with fever fall short of the NMCP goal of 80% coverage by 2010 and universal coverage thereafter. Given
the ability to treat a child with malaria differs greatly between treatment locations, policy and logistics planning
should address the shortages of essential malaria supplies in recommended and frequently accessed treatment
locations. Particular emphasis should be placed on integrating the private sector into standardized care and
educating caregivers on the necessity for testing before treatment and the availability of free ACT in public health
facilities for uncomplicated malaria.
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Malaria is a parasitic illness that affects millions around
the world each year. The World Health Organization
(WHO) estimates that in 2012 there were 207 million
malaria cases and 627,000 malaria deaths globally; 77%
of these were in children under five years of age [1]. The
majority of malaria deaths are amongst children in Africa,
where malaria kills one child every minute [2]. In fact,
malaria accounts for 7% of deaths in children under five
globally [3].
Nigeria is particularly afflicted by this disease. Malaria
is the leading cause of child mortality in the nation and
accounts for 30% of hospitalizations, 60% of outpatient
visits [4], and 30% of deaths among children under five
[5]. In 2008, there were about 100 million suspected
cases and 300,000 deaths due to malaria in Nigerian
children under five [6].
When prevention fails, effective malaria case manage-
ment is key for preventing morbidity and mortality for
children under five. Three priority areas of malaria case
management—as identified by the WHO in 2010 [7]
and adopted by the Nigeria National Malaria Control
Programme (NMCP) [8]—are (1) prompt care-seeking
within the first 24 hours of symptoms; (2) performance
of a parasitological blood test, by either microscopy or
rapid diagnostic testing (RDT), to prevent over- and
under-diagnosis of malaria; and (3) administration of
artemisinin-based combination therapy (ACT) if the
blood test is positive [7]. ACT has been designated as
the first-line treatment for its ability to reduce drug resist-
ance and its efficacy in treating malaria [7]. Prompt, accur-
ate diagnosis and treatment of malaria is essential to
prevent death since the majority of malaria deaths occur
within the first 24 hours following onset of fever [5].
In Nigeria, ACT was introduced as first-line treatment
in 2005 and RDTs were recommended for diagnosis in
2007. The NMCP strategy for 2009–2013 [9] set a goal
target of 80% of malaria cases to be diagnosed with a
blood test and treated with an ACT within the first
24 hours of fever onset [8] by 2010 and universal coverage
thereafter, based on goals set by RBM [6].
Despite sound policies, goals, and improvements in
prevention through increased coverage of insecticide-
treated nets (ITNs) [10,11], malaria case management
has continued to be inadequate in Nigeria due to weak
health systems [12,13]. As of 2013, in Nigeria, 70.1% of
children under five with fever sought advice or treat-
ment, only 11.1% received a blood test, 6.0% received an
ACT and 4.2% received an ACT within 24 hours of fever
onset [11]. Also, 30.9% of Nigerian children who sought
treatment for malaria received chloroquine [11], a com-
mon anti-malarial, deemed ineffective in Nigeria due to
resistance since the 1980s [14]. When stratified by geo-
political zone (GPZ), treatment rates were lowest in theNorth West and North East GPZs with only 6.7% and
8.7% receiving a blood test and 3.5% and 2.0% receiving
an ACT within 24 hours of fever onset, respectively [11].
While regional data are helpful in identifying disparities
generally, there is limited state-level data on malaria case
management, or treatment, and patient care-seeking pat-
terns. The 2013 Demographic and Health Survey for
Nigeria details treatment received by state, but does not
detail where children seek care and the treatment they re-
ceive there, by state [11]. However, this information is im-
portant and can help determine if FMOH goal coverage
rates/NMCP strategies are being met, and inform policy
and programme implementation by state MOHs, NGOs,
and other organizations to improve case management
[15]. Given the high burden of disease and poor health
systems in these regions, this information is especially
important.
To help address this paucity of information, a cross-
sectional study was conducted in two states in Northern
Nigeria. The primary aim of the study was to describe
the current care-seeking and treatment pattern for chil-
dren under five with fever in Northern Nigeria. The sec-
ondary aims were to determine how many children with
fever receive treatment consistent with NMCP/WHO
standards and which factors help predict if a child under
five with fever is taken to treatment, none of which have
been studied in Nigeria to date.
Methods
Setting area and background
Nigeria—the most populous country in Africa with 140
million people [16]—is comprised of six geopolitical
zones (GPZs), 36 states, and 774 Local Government Areas
(LGAs). Northern Nigeria is historically underserved and
suffers the highest infant mortality rate (IMR) and under
five mortality rate (U5MR) [11]: the North East and North
West GPZs have an IMR of 77 and 89 per 1,000 live births
[11] and a U5MR of 160 and 185 per 1,000 live births [11],
respectively. This is higher than the national IMR of 69 per
1,000 live births and U5MR of 128 per 1,000 live births [11].
In order to address these regional disparities, the
Targeted States High Impact Project (TSHIP)—a five-
year reproductive, maternal, newborn and child health
and family planning (RMNCH/FP) program—was imple-
mented in Bauchi, a state with a population of 4.6 mil-
lion in the North East GPZ, and Sokoto, a state with a
population of 3.7 million in the North West GPZ [16].
TSHIP—implemented by JSI Research and Training In-
stitute, Inc. from 2009 through 2015—was the first
United States Agency for International Development
(USAID) full-state approach to providing RMNCH/FP
services in Nigeria. This approach addressed the chal-
lenges of effective donor collaboration, program efficacy,
and health systems strengthening. Malaria interventions,
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were implemented in these states through TSHIP.
Bauchi and Sokoto experience the highest transmission
of malaria from April to October.
In order to contextualize malaria care-seeking, under-
standing the structure of the Nigerian health care system
is necessary, as well. In the public sector there are dis-
pensaries, primary health facilities (e.g., Primary Health
Clinics [PHCs]), secondary facilities, and tertiary hospi-
tals [8]. The private sector is made up of patent medi-
cine vendors (PMVs), private clinics and hospitals. The
Ministry of Health (MOH) is responsible for providing
operational supervision to the private sector to ensure
compliance standards. However, enforcing these stan-
dards is difficult due to inadequate numbers of qualified
personnel to carry out this task [17].
Despite poor regulation and standards of care, the lar-
gest source of treatment for children (and adults) with
fever is PMVs (45.6%) and the second largest are govern-
ment health facilities (33.8%) [11]. This is alarming due
to the fact that PMV staff lack formal training and
supervision [17] and serve a large proportion of patients.
In addition to high mortality rates and poor service
delivery, commodity management is also poor in this re-
gion. Drug supply management has been an on-going
problem, especially at the PHC level [13]. A stock-out
analysis of ACTs and RDTs done by TSHIP in SokotoFigure 1 Map of Nigeria: Bauchi and Sokoto highlighted.showed a deficit of 2 million ACT doses and 700 thou-
sand RDTs to meet the current malaria burden [18].
Thus, data to help identify patterns in care-seeking will
allow us to inform programmatic and policy activities to
strengthen malaria case management and to better serve
rural and underserved populations.
Study design and implementation
In November and December 2012, a relatively low period
of malaria transmission, a cross-sectional lot quality assur-
ance sampling (LQAS) survey was administered propor-
tionally throughout each of the 20 LGAs in Bauchi and 23
LGAs in Sokoto (Figure 1 [19]). This was the baseline
survey of an annual survey for monitoring and evaluation
for TSHIP.
LQAS originated in the manufacturing sector to test
the quality of a lot of goods. However, several studies
and health programmes have used LQAS as a method-
ology to assess programme coverage and performance
indicators in public health [5,20]. This method of sam-
pling divides a programme area into smaller geographic
“lots,” or supervision areas, and then samples house-
holds from each lot. The results are then compared with
a decision rule, or benchmark value, to help local TSHIP
planners identify areas that are meeting or failing the
benchmark value. This ability to prioritize the most vul-
nerable areas is crucial when resources are limited.
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of the LQAS survey, which covered topics on maternal,
newborn, and child health; malaria; and family planning to
assess TSHIP’s programmatic activity. The data from
“Questionnaire 8: Mothers of children 0 to 59 months
with fever in the last 2 weeks” as well as “Questionnaire 1:
Women of reproductive age with children aged 0 to
59 months” are used in this paper.
In Bauchi and Sokoto, each LGA acted as a lot or a
supervision area. Within each lot, 19 settlements (villages)
were randomly selected, proportional to population and
representative of each LGA, to complete one comprehen-
sive LQAS survey. LQAS methodology is based on a deci-
sion rule of choosing 12–30 settlements per lot. Nineteen
settlements per lot have been proven to give a good fit for
an annual coverage target of 50% or below with a sensitivity
of 95% [21]. A household in each settlement was randomly
selected and all applicable questionnaires were completed.
If a selected household was not eligible to answer all nine
questionnaires, the surveyor moved on to the next house-
hold to finish the remaining questionnaires. This approach,
called “parallel sampling”, is unique to LQAS. If a settle-
ment was too small to complete all nine questionnaires, a
neighboring settlement was visited to complete the survey.
In a household where two or more eligible respondents
were found, one respondent was randomly selected. Inter-
viewers were trained on the LQAS methodology and use of
the pre-tested tools over a period of five days. Question-
naire 1 contained detailed maternal demographic questions.
The questionnaire (number 8) on malaria included ques-
tions about maternal and child’s age, whether treatment
was sought outside of the home, promptness of treatment,
location of treatment, whether the child received a diagnos-
tic test (either microscopy or RDT), whether the child took
a medication, and what type of medication the child took.
In this analysis, we combine all of the small samples to
create an unbiased random sample of 814 households
representing the states of Bauchi (n = 379) and Sokoto
(n = 435). With this much larger sample size, there is
more power to describe care-seeking and treatment pat-
terns, and identify differences between the two states.
Using the chi-square test, a 5% significance level, and
the given sample sizes, there is 80–90% power to identify
a 10% or greater difference between the states across the
range of possible response percentages. Moreover, per-
centages reported for an individual state, or both states
combined, have margins of error ranging from 2–5%.
Participants
Both the first and malaria questionnaires included women
of reproductive age (15–49 years old) with children aged
0–59 months. The malaria questionnaire only included
children who had a fever in the last two weeks. Detailed de-
scriptive and demographic information is reported from thefirst questionnaire, since it was not collected on the malaria
questionnaire. Some, but not all, mothers completed both
questionnaires. Since both questionnaires focused on the
same target population in the same villages the demo-
graphics should represent the women who completed the
malaria questionnaire. Maternal and child age, and child’s
sex, which were ascertained on both questionnaires, were
statistically similar between the two survey samples.
Variables
Prompt treatment was defined as treatment on either the
same or following day (24 hours) of fever onset based on
recommendations from the RBM Partnership [6]. In
addition, if the mother said the child received treatment,
but indicated location of treatment as home and provider
as self, the child was re-categorized as not receiving
treatment, since treatment was not sought outside of the
home.
Treatment location was categorized into formal and
informal sectors. Formal treatment locations included
health facilities and private doctors. Informal treatment
locations included PMVs, community based health vol-
unteers (CBHV), traditional practitioners, and other. In-
cluded in the informal “other” category are unauthorized
drug sellers, friends/relatives, and other.
Statistical methods
To assess the primary aim of defining current care-
seeking and treatment patterns for children under five
with fever, frequencies of survey question responses were
computed. Responses were also cross-classified by state,
and the chi-square test was used to assess the statistical
significance of geographic differences. To address a sec-
ondary aim of comparing these results to the NMCP/
WHO standard case management pathway, results were
organized according to the standard and the number
and percent of respondents meeting each component of
the case management pathway was estimated. Epi Info
version 7 [22] was used for data entry and data cleaning
and Stata/IC 12.1 [23] was uses for data analysis.
To assess another secondary aim—identifying whether
maternal age, child age and gender, and state help predict
if a child under five with fever is taken to treatment—a
binary logistic regression was performed with seeking
treatment as the dependent variable. Akaike information
criterion and likelihood ratio tests (LRTs) were used to as-
sess the explanatory power of the model and identify fac-
tors that contributed significantly to each model.
Ethical approval
Ethical approval was granted by the Sokoto and Bauchi
State Health Research Ethics Committee and by local
leaders in the study area. Approval from the National
Health Research and Ethics Committee is not required
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Table 1 showcases the descriptive statistics of the study
population. Stratification of the data by state showsTable 1 Socio-demographic characteristics of mothers and ch




Mean age (SD) 25.2 (6.3) 26.9
15–19 years 58 15.3% 59
20–24 years 114 30.1% 90
25–29 years 93 24.5% 104
30–34 years 73 19.3% 107
35–49 years 41 10.8% 75
Education*
No education 263 69.4% 387
Primary education 77 20.3% 27
Secondary education 30 7.9% 8
Higher education 9 2.4% 5
Religion
Muslim 352 92.9% 429
Catholic 3 0.8% 1
Other christian 22 5.8% 2
Traditionalist 2 0.5% 3
Marital status
Married 376 99.2% 422
Not-married 3 0.8% 13
Children’s characteristics
Age
Mean (SD) 16.0 (12.3) 17.9
0–6 months 93 24.5% 92
7–12 months 87 23.0% 95
13–18 months 79 20.8% 61
19–24 months 57 15.0% 96
25–59 months 63 16.6% 91
Sex
Male 199 52.5% 234
Female 180 47.5% 201
Household characteristics
Multifamily household 34 9.0% 95
Bold values are significant at a p <0.05 level.
*Eight missing values for education. 814 used as denominator (N = 806).significant demographic differences between states (p <0.05).
Therefore, further analyses were done with all data com-
bined and stratified by state. Of the 818 women and chil-
dren pairs that answered this survey, four were excluded
because they did not meet age criteria. Therefore, 814
woman and child pairs were included in the analysis.
Mean maternal age was 26.1 (15–48) years. The vast
majority of mothers had no education (79.8%, 650) andildren under five with fever
oto (N = 435) Total (N = 814) P-value
% N %
(6.7) 26.1 (6.6) 0.0002













97.0% 798 98.0% 0.02
3.0% 16 2.0%
(13.0) 17.0 (12.7) 0.03








21.8% 129 15.8% <0.0001
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cation (1.7%, 14). The proportion of uneducated women
was significantly greater in Sokoto (89.0%, 387) than
Bauchi (69.4%, 263) (p <0.001). Most mothers were
Muslim (96%, 781) and married (98%, 798). Children’s ages
ranged from 0–59 months with a mean age of 17.0 months.
Of the children, 53.2% (433) were male and 46.8% (381)
were female. In addition, 15.8% (129) of mother and child
dyads were part of a multifamily household.
Treatment seeking behaviour
Of children under five with fever in the past two weeks,
76.7% (624) were brought to treatment. Of those chil-
dren who were brought to treatment outside of the
home (624), 61.5% (384) followed WHO and NMCP
standards to do so promptly, 46.0% (287) received treat-
ment in the formal sector and 54.0% (337) receivedTable 2 Care-seeking and treatment patterns for children und





Bauchi (N = 299)
Location of first-line treatment or advice sought
Formal 146 48.8%
Health facility 138 46.2%




Traditional Practitioner 5 1.7%
Otheri 7 2.3%
Timing of first-line treatment
Prompt 192 64.2%
Not Prompt 107 35.8%
Treatment
Received diagnostic blood test 30 10.0%
Received medication 245 81.9%
Received non-anti-malarial medication 131 46.4%
Received anti-malarial 114 38.1%
Received prompt anti-malarial 73 24.4%
Received non-ACT anti-malarial 79 28.0%
Received prompt non-ACT anti-malarial 51 18.1%
Received ACT 35 11.7%
Received prompt ACT 22 7.4%
Bold values are significant at a p <0.05 level.
iFriend/Relative/Unauthorized Drug Seller/Other.treatment in the informal sector. These behaviours did
not differ by state.
Treatment was most often sought at PMVs (45.5%,
284), followed by health facilities (43.8%, 273). The re-
mainder sought care at CBHVs, private doctors, trad-
itional practitioners, and other sources (3% or less of the
time, respectively) (Tables 2 & 3). Treatment location
differed by state only for CBHVs, with children accessing
them 4.6% (15) of the time in Sokoto and 1.7% (5) of the
time (p = 0.04) in Bauchi (Table 2).
Testing
Of children who sought treatment, only 9.8% (61) received
a blood test (Table 2). Children were most likely to receive
a blood test if they received treatment at a health facility
(15.0%, 41), next at a private doctor (14.3%, 2), traditional
practitioner (6.7%, 1), and, last, a PMV (6.0%, 17) (Table 3).er five with fever
Sokoto (N = 435) Total (N = 814) P-value
N % N %
325 74.7% 624 76.7% 0.16
110 25.3% 190 23.3%
Sokoto (N = 325) Total (N = 624)
141 43.4% 287 46.0% 0.17
135 41.5% 273 43.8% 0.24
6 1.8% 14 2.2% 0.45
184 56.6% 337 54.0% 0.17
148 45.5% 284 45.5% 1.00
15 4.6% 20 3.2% 0.04
10 3.1% 15 2.4% 0.26
11 3.4% 18 2.9% 0.41
192 59.1% 384 61.5% 0.19
133 40.9% 240 38.5%
31 9.8% 61 9.8% 0.84
237 72.9% 482 77.2% 0.02
102 35.3% 233 37.3% 0.38
135 41.5% 249 39.9% 0.38
92 28.3% 165 26.4% 0.27
107 37.0% 186 29.8% 0.004
69 21.2% 120 19.2% 0.01
28 8.6% 63 10.1% 0.20
23 7.1% 45 7.2% 0.89
Table 3 Care-seeking patterns and treatment by location
Prompt treatment Test done Anti-malarial given ACT given Other medication given
Health facility (273) 58.6% (160) 15.0% (41) 46.5% (127) 14.3% (39) 29.3% (80)
Private doctor (14) 71.4% (10) 14.3% (2) 35.7% (5) 14.3% (2) 42.9% (6)
PMV (284) 64.4% (183) 6.0% (17) 38.0% (108) 7.0% (20) 40.8% (116)
CBHV (20) 45.0% (9) 0% 25% (5) 10.0% (2) 45% (9)
Traditional practitioner (15) 73.3% (11) 6.7% (1) 13.3% (2) 0% 66.7% (10)
Other (18) 61.1% (11) 0% 11.1% (2) 0% 66.7% (12)
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Of children who received treatment, 39.9% (249) re-
ceived an anti-malarial, however 29.8% (186) received a
non-ACT anti-malarial and only 26.4% (165) received a
prompt anti-malarial (Table 2). A child was most likely
to receive an anti-malarial if they went to a health facility
(46.5%, 127), next at a PMV (38%, 108), private doctor
(35.7%, 5), CBHV (25%, 5), and traditional practitioner
(13.3%, 2) (Table 3).
An even smaller proportion of children received a
WHO and NCMP recommended ACT (10.1%, 63), and
only 7.2% (45) received a prompt ACT (Table 2). Children
were most likely to receive an ACT (14.3%) if they received
treatment at a health facility (39) or private doctor (2), nextFigure 2 Medication type given by treatment location to children und
who sought care at that location.from a CBHV (10.0%, 2) and then a PMV (7.0%, 20)
(Table 3, Figure 2). Children were most likely to receive a
prompt ACT if they received treatment at a health facility
(10.6%, 29), next a private doctor (7.1%, 1), and last a PMV
(5.3%, 15) (Figure 2). Treatment results did not differ by
child’s sex (p ≥0.17), but did occasionally differ by state
(p <0.02) (Table 2).
Treatment based on national policy/WHO recommended
pathway
Figure 3 illustrates the NMCP/WHO standard treatment
pathway. Of children under five who had a fever in the
last two weeks (814), 47.2% (384) sought prompt treat-












Malaria symptoms Sought prompt
treatment


















Figure 3 Treatment pathway for children under five with fever who received NMCP/WHO standard care.
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received a blood test, 1.0% (8) of the total sample received
an ACT.
In addition, Figure 4 illustrates which proportion of
children received the NMCP/WHO standard of care
stratified by treatment location. Of all locations, health
facilities provided the greatest percentage of NMCP/
WHO standard care (0.9%, 7). PMVs and traditional
practitioners each treated one patient according to theFigure 4 Treatment pathway for children under five with fever who r
boxes are proportions of all febrile children.NMCP/WHO standard, accounting for 0.1% of children
with fever, respectively.
Predictors of treatment seeking
Table 4 presents the results of the logistic regression cre-
ated to identify factors that help predict whether a child
received treatment outside of the home. The results
show that neither state, mother’s age, nor child’s sex was
significantly related to treatment seeking. Child’s ageeceived NMCP/WHO standard care, by location. Percentages in
Table 4 Multivariable logistic regression models of the
odds of seeking any treatment for a child under five
years with fever from any location
Unadjusted (OR) Adjusted (OR)
Total Total
Variable OR 95% CI P value OR 95% CI P value
Mother’s age 1.00 0.98, 1.03 0.33 1.00 0.98, 1.03 0.84
Child’s age
0–6 months 1.0 1.0
7–59 months 1.72 1.19, 2.48 0.004 1.74 1.16, 3.03 0.003
Childs sex
Male 1.0 1.0
Female 0.87 0.63, 1.20 0.40 0.86 0.62, 1.20 0.38
State
Bauchi 1.0 1.0
Sokoto 0.79 0.57, 1.10 0.16 0.77 0.55, 1.07 0.12
Bold values are significant at a p <0.05 level.
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pattern was not strictly linear. The clearest indication
from the data was that treatment seeking was less likely
for children under the age of six months. There was a
significantly greater odds of seeking treatment for 7–59
month olds (OR: 1.74, p = 0.003) compared to 0–6
month olds, adjusted for mother’s age, child’s sex, and
state.Discussion
Care-seeking
Rates of treatment, prompt treatment, and formal sector
treatment in Northern Nigeria are 77%, 47%, and 35%
respectively (N = 814). This rate of treatment seeking is
consistent with a 2013 study in Nigeria in which 70% of
parents of children under five sought advice or treat-
ment [11]. These rates are also slightly higher than rates
discovered in a similar study of malaria treatment in
Senegal where 62% of children under five with fever in
the last two weeks received treatment, 40% received
prompt treatment, and 32% received treatment from the
formal sector [15]. However, there is much room for im-
provement since the malaria treatment seeking rates in
Benin, DRC, Madagascar, Uganda, and Zambia are signifi-
cantly higher (83 – 95%) [22]. Since only 47% of caregivers
sought prompt care and 35% sought formal care, future
programmatic emphasis may be placed on educating care-
givers where and how quickly they need to seek treatment
for children under five with fever. Future research in this
area may also focus on assessing recognition of malaria
symptoms and knowledge of case management strategies
among families with children under five years old.Location of care
PMVs were found to be the preferred treatment pro-
viders, with 46% of all children under five with fever
receiving treatment from this location. This is consistent
with the national rate of 46% [11] and other areas such
as the Kabale district in Uganda (53%) [23]. One reason
for this may be that families feel that local private
providers are more accessible, are more sensitive to the
patients’ needs, and spend more time with them than
public sector providers [24,25]. However, there are key
problems with this sector including inappropriate stor-
age [25], knowledge, and dosing of drugs [24,26].
Another downfall of seeking treatment at a PMV is
that they are not authorized to administer diagnostic
tests [personal communication, Dr. Mohammed Ibrahim].
This was evident by a recent survey that found microscopy
completely unavailable at PMVs and RDTs available at 1%
of PMVs [27]. In order to promote all steps in the malaria
case management pathway, policy recommendations are
to facilitate stocking of and training of staff in the use of
RDTs at PMVs. In addition, when RDTs were imple-
mented in the private sector, providers were not knowl-
edgeable in treatment for non-malaria fever, which
resulted in treatment with an ACT despite a negative
RDT [28]. Therefore, capacity development and quality as-
surance of this sector is an important piece to improving
malaria case management.
Less than half (44%) of the parents sought treatment
for their children from a health facility, even though
health facilities provided the largest proportion of
children with recommended case management (Table 3).
This rate is actually higher than the national rate of
children receiving care at a public facility (35%) [11].
Use of diagnostic tests
Despite a national benchmark to promptly test 80% of
children under five with fever [8], in this study, children
rarely received a blood test (8% of sample, 10% of care-
seeking children). This is lower than the national rate of
11% [11], and much less than the average rate across 13
sub-Saharan African countries (17%) [29] and Rwanda
(30%) [30], but higher than the rate of testing in Sierra
Leone (1%) [31].
Although health facilities tested the largest proportion
of children in this study (15%), that proportion is far
below the testing rate of 95% in health facilities in
Zambia [32]. In order to bridge the current gap between
NMCP/WHO standard and current treatment, policies
and programmes may focus on making blood tests
and ACT more consistently available. A survey done by
ACTwatch throughout Nigeria in 2011 showed that
microscopic testing was more available than RDTs [27],
therefore policies and initiatives to improve diagnostic
testing should be consistent with commodity availability
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anti-malarials in the last three months, only 26% of public
health facilities, 37% of private for profit facilities, and 1%
of PMVs offered any testing services [27]. These stock-
outs are a key weakness is the ability of facilities to provide
diagnostic blood testing consistent with WHO/NMCP
standards for malaria case management.
Treatment given
Of anti-malarials given, 75% were non-ACT, much higher
than the national average of 26% [11] This is of great con-
cern because malaria is resistant to many anti-malarials in
Nigeria [8] and ACT has been the standard of care since
2005 [6]. The rate of standard treatment using prompt
ACT is 7%; higher than the national rate of 4%, but much
lower than a study in Tanzania (38%) [33]. It is likely that
a combination of factors influence the low ACT rate. For
example, a 2008 study showed only 36% of PHC health
workers in Sokoto had adequate knowledge of malaria
case management [34]. In addition, another study showed
that only 49% of public facilities in Nigeria have at least
one quality assured first-line dose of ACT [35].
Given the fact that PMVs are the most commonly
accessed treatment location, interventions to strengthen
their role in malaria case management may result in im-
proved outcomes. In Kenya, an intervention that subsi-
dized ACT for retail outlets, trained retail outlet workers,
and strengthened community awareness of case manage-
ment standards, saw a 25% increase in ACT treatment for
children under five. In addition, a USAID report recom-
mends engaging the private and even informal sector to
improve coverage and case management of child illness
[24]. Policy and logistics planning should address the lack
of training and shortages of essential malaria commodities
in recommended and frequently accessed treatment
locations.
Given the current stock-outs of ACT and RDTs [18] in
Sokoto State, commodity procurement and logistics
need to be improved to bridge the gap between available
and needed RDTs and ACT. Further research may be
needed to understand weaknesses in the supply chain
and training of health professionals. Future program-
matic and policy activity should focus on strengthening
these aspects of health care infrastructure.
Overall and NMCP/WHO standard treatment patterns
While the majority of caregivers (77%) seek treatment
for children under five presenting with fever, when care-
seeking pathways are studied, only 1% of children under
five with fever receive treatment according to WHO and
Nigeria’s NMCP standards: prompt care-seeking, diagno-
sis with an RDT, and treatment with an ACT. This
leaves a staggering discrepancy between the Nigeria
NMCP and RBM goal coverage rate of 80% for promptRDT use and subsequent ACT treatment if indicated
[4,6,8] and the actual rate among children under five
with fever in Northern Nigeria (Figure 3).
Policy and caregiver education strategies are import-
ant, but will have limited effect on improving malaria
case management if health systems remain weak. In
Nigeria, current health system weaknesses include stock-
outs due to poor procurement and supply chains for
malaria commodities in the public health sector, weak
delivery of health services in public facilities, lack of
necessary and adequately-trained human resources for
health, and nearly non-existent diagnostics [4].
The poor state of malaria care in Sokoto and Bauchi
could be improved by strengthening national policy and
regulatory power in the informal sector. Since informal
sector regulation and systems strengthening is often a
difficult a lengthy process, incentives such as vouchers or
conditional cash transfers may be used to direct patients
toward the formal sector until the private and informal
sector is can correctly deliver malaria case management.Predictors of treatment
Child’s age was a significant predictor in the regression
for seeking treatment versus not seeking treatment.
However, our modeling was limited by the number of
variables on the malaria questionnaire. Thus, other fac-
tors may be as, or more, predictive of seeking treatment.
However, cultural practice could plausibly contribute to
the age differences. Several studies have shown that
physical confinement is common in Nigerian postpar-
tum practices—often lasting 40 days [36-38]. Confine-
ment has implications for the ability of the mother to
seek care for her febrile newborn and may have affected
the decreased odds of seeking care for 0–6 months.
However, this information may be inconclusive due to
the limitations in variables and sample size. Further
research should be done to assess factors that facilitate
recommended malaria case management.Limitations
There are some limitations to using a study based on
LQAS methodology to assess care-seeking behaviour of
parents. LQAS methodology is designed to cost-effectively
compare programme coverage rates with set thresholds to
evaluate programme performance. Thus, LQAS surveys
typically have relatively small sample sizes (low power)
and a relatively limited number of questions. This makes
it difficult to perform more complex statistical analyses to
establish causal and associative relationships. However,
with over 800 respondents, there was good power to
assess care-seeking, with a margin of error of only 2–5%
for each question, but a limited number of explanatory
variables.
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area, the survey did not assess whether each household
was comprised of a polygamous or monogamous family;
a study in Ethiopia found that mothers in a monogam-
ous marriage had 3.4 greater odds of seeking treatment
for a child under five with fever than mothers in a polyg-
amous marriage [39]. The survey did not specifically ask
if medications were procured at location of first line
treatment or elsewhere. Thus, it is assumed that the
medication was obtained from the first place of treat-
ment. Lastly, the study did not assess the result of the
diagnostic blood test. This is a limitation to assessing
quality of treatment, since the proportion who received
a medication cannot be compared to those who were di-
agnosed with malaria. However, malaria prevalence rates
are so high in these areas, it is assumed the majority of
fever cases were malaria.
Several types of bias may have been introduced in the
study, but should not affect the conclusions of the analysis.
Recall bias is a risk given this was a retrospective cross-
sectional survey, compounded by the fact that largely
uneducated women were asked to recall complex informa-
tion. However, this bias should be minimal since the
maximum time that had to be recalled was two weeks.
Misclassification bias was minimized by only classifying a
child as receiving treatment if the mother answered both
yes to the child receiving a medication and listed what the
medication was, even if it was “other” or “unknown”.
Conclusions
Nigeria’s NMCP goal coverage rates of 80% for NMCP
and WHO standard malaria case management for children
under five with fever in Northern Nigeria are far from be-
ing met. Although the best care is provided in health facil-
ities, children are most likely to visit a PMV for first-line
treatment of fever. The implementation of national policy
change is stunted by drug stock-outs, inadequately trained
service providers, and caregivers of children under five
with a lack of knowledge of correct malaria treatment.
Given the ability to treat a child with malaria differs
greatly between facility types, policy and logistics planning
should address the shortages of essential malaria com-
modities in recommended and frequently accessed treat-
ment locations. Particular emphasis should be placed on
integrating the private sector into standardized care and
educating caregivers on the necessity for testing before
treatment and availability of free ACT in public health
facilities for the treatment of uncomplicated malaria.
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